Tuesday, November 5, 2024
Facebook Linkedin Twitter
HomeTagsGracell Biotechnologies

Gracell Biotechnologies

Biotechnology

Gracell Biotechnologies Presents Updated Clinical Data for BCMA/CD19 Dual-targeting FasTCAR GC012F

PR Newswire -
Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced the...
Biotechnology

Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022

PR Newswire -
Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced the...
Biotechnology

Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating

PR Newswire -
Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced that...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us